Given that EGF can also stabilize CHD6, it is then conceivable that CHD6 participates in both EGF and Wnt signaling pathways, which have major impacts in promoting the development of CRC (Fig. 9). The gene discussed is CHD6; the disease is colorectal carcinoma.